Lineage Cell Therapeutics Inc(LCTX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

LCTX Lineage Cell Therapeutics Inc

休市中 09-04 16:00:00 EDT

1.08

-0.02

-1.82%

盘后1.10

+0.02+1.85%

19:30 EDT

最高1.11	最低1.08	成交量53.57万
今开1.09	昨收1.10	日振幅2.27%
总市值2.73亿	流通市值2.06亿	总股本2.53亿
成交额58.32万	换手率0.28%	流通股本1.91亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"LCTX","market":"US","secType":"STK","nameCN":"Lineage Cell Therapeutics Inc","latestPrice":1.08,"timestamp":1788552000000,"preClose":1.1,"halted":0,"volume":535726,"hourTrading":{"tag":"盘后","latestPrice":1.1,"preClose":1.08,"latestTime":"19:30 EDT","volume":4702,"amount":5088.6208,"timestamp":1788564603422,"change":0.02,"changeRate":0.018519,"amplitude":0.018519},"delay":0,"changeRate":-0.018181818181818195,"floatShares":191000000,"shares":252907464,"eps":-0.185503,"marketStatus":"休市中","change":-0.02,"latestTime":"09-04 16:00:00 EDT","open":1.09,"high":1.105,"low":1.08,"amount":583214.0383824,"amplitude":0.022727,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.185503,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1788854400000},"marketStatusCode":7,"adr":0,"listingDate":699771600000,"exchange":"AMEX","adjPreClose":1.1,"preHourTrading":{"tag":"盘前","latestPrice":1.1,"preClose":1.1,"latestTime":"09:24 EDT","volume":6373,"amount":6996.488434399999,"timestamp":1788528283001,"change":0,"changeRate":0,"amplitude":0.025818},"postHourTrading":{"tag":"盘后","latestPrice":1.1,"preClose":1.08,"latestTime":"19:30 EDT","volume":4702,"amount":5088.6208,"timestamp":1788564603422,"change":0.02,"changeRate":0.018519,"amplitude":0.018519},"volumeRatio":0.7299942635129579,"impliedVol":3.23,"impliedVolPercentile":0.9008},"requestUrl":"/m/hq/s/LCTX","defaultTab":"news","newsList":[{"id":"1133108902","title":"Lineage Cell Therapeutics 将于2026年8月6日发布第二季度财报并更新业务进展","url":"https://stock-news.laohu8.com/highlight/detail?id=1133108902","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1133108902?lang=zh_cn&edition=full","pubTime":"2026-07-30 20:01","pubTimestamp":1785412877,"startTime":"0","endTime":"0","summary":"Lineage Cell Therapeutics Inc（股票代码：LCTX）宣布，计划于2026年8月6日公布其2026年第二季度财务业绩，并同步提供业务最新动态。这家专注于细胞疗法研发的生物科技公司，届时将向投资者及市场详细解读季度表现与未来战略方向。这一消息引发市场对其临床试验进展与财务状况的持续关注。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LCTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1132292117","title":"Lineage Cell Therapeutics将推进Cor1进入体内动物试验，初步数据预计今年出炉","url":"https://stock-news.laohu8.com/highlight/detail?id=1132292117","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1132292117?lang=zh_cn&edition=full","pubTime":"2026-07-13 20:03","pubTimestamp":1783944231,"startTime":"0","endTime":"0","summary":"Lineage Cell Therapeutics公司宣布，将推进其候选产品Cor1进入体内动物试验阶段，预计初步数据将于今年内获得。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LCTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146969548","title":"Lineage Cell Therapeutics将于2026年5月12日公布2026年第一季度财报并举行业务进展说明会","url":"https://stock-news.laohu8.com/highlight/detail?id=1146969548","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1146969548?lang=zh_cn&edition=full","pubTime":"2026-05-05 20:01","pubTimestamp":1777982487,"startTime":"0","endTime":"0","summary":"生物技术公司Lineage Cell Therapeutics Inc（股票代码：LCTX）近日宣布，将于2026年5月12日发布2026年第一季度财务业绩报告。此次公告将全面披露公司在该季度的经营表现和财务数据。\n同时，管理层将举行业务更新会议，深入阐述公司最新研发进展、战略规划及未来展望。投资者可通过指定渠道参与实时交流，获取第一手企业动态。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LCTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617583816","title":"Lineage Cell Therapeutics, Inc.盘中异动 早盘股价大涨5.43%报1.94美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2617583816","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2617583816?lang=zh_cn&edition=full","pubTime":"2026-03-06 22:31","pubTimestamp":1772807502,"startTime":"0","endTime":"0","summary":"北京时间2026年03月06日22时31分，Lineage Cell Therapeutics, Inc.股票出现异动，股价急速上涨5.43%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.27%。其相关个股中，Day One Biopharmaceuticals, Inc.、Solid Biosciences Inc.、Moolec Science Sa C/Wts 30/01/2028涨幅较大，Day One Biopharmaceuticals, Inc.、Quince Therapeutics, Inc.、Reviva Pharmaceuticals Holdings, Inc.较为活跃，换手率分别为26.07%、19.67%、16.48%，振幅较大的相关个股有Moolec Science Sa C/Wts 30/01/2028、Contineum Therapeutics, Inc.、Cartesian Therapeutics, Inc.，振幅分别为24.36%、9.30%、7.69%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260306223142954392bd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260306223142954392bd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","LENZ","BK4224","LINE","LCTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1166565406","title":"Lineage Cell Therapeutics 2024年第四季度GAAP每股收益$(0.02) 超过预期$(0.03)，销售额$2.900百万 超预期$1.621百万","url":"https://stock-news.laohu8.com/highlight/detail?id=1166565406","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1166565406?lang=zh_cn&edition=full","pubTime":"2025-03-11 04:08","pubTimestamp":1741637306,"startTime":"0","endTime":"0","summary":"公司报告季度销售额$2.900百万，超过了分析师共识预估的$1.621百万，提高了78.88%。与去年同期的销售额$2.100百万相比，这一数字增长了38.10%。以上内容来自Benzinga Earnings专栏，原文如下：$Lineage$ Cell $Therapeutics$  reported quarterly losses of $ per share which beat the analyst consensus estimate of $ by 33.33 percent. This is a 33.33 percent increase over losses of $ per share from the same period last year.  The company reported quarterly sales of $2.900 million which beat the analyst consensus estimate of $1.621 million by 78.88 percent.  This is a 38.10 percent","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LCTX","LINE","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518527621","title":"Lineage Cell Therapeutics, Inc.盘中异动 早盘快速上涨7.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518527621","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518527621?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:39","pubTimestamp":1741613947,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时39分，Lineage Cell Therapeutics, Inc.股票出现波动，股价急速上涨7.06%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.40%。其相关个股中，Trevi Therapeutics, Inc.、Checkpoint Therapeutics, Inc.、Scisparc Ltd.涨幅较大，Scisparc Ltd.、Dogwood Therapeutics, Inc.、Aeon Biopharma, Inc.较为活跃，换手率分别为487.59%、74.68%、56.14%，振幅较大的相关个股有Scisparc Ltd.、Impact Biomedical, Inc.、Trevi Therapeutics, Inc.，振幅分别为34.57%、28.59%、25.35%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213908964037cc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213908964037cc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LINE","LENZ","BK4224","LCTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517160017","title":"Lineage Cell Therapeutics, Inc.盘中异动 股价大涨5.53%报0.548美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517160017","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517160017?lang=zh_cn&edition=full","pubTime":"2025-03-07 00:51","pubTimestamp":1741279881,"startTime":"0","endTime":"0","summary":"北京时间2025年03月07日00时51分，Lineage Cell Therapeutics, Inc.股票出现异动，股价急速拉升5.53%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.46%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307005121989ece5b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307005121989ece5b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","LINE","BK4224","LCTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517028306","title":"Lineage Cell Therapeutics, Inc.盘中异动 股价大涨5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517028306","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517028306?lang=zh_cn&edition=full","pubTime":"2025-03-05 01:32","pubTimestamp":1741109577,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日01时32分，Lineage Cell Therapeutics, Inc.股票出现异动，股价大幅上涨5.02%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.03%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305013257a25f3654&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305013257a25f3654&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4224","LENZ","BK4139","LCTX","LINE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516344637","title":"Lineage Cell Therapeutics, Inc.盘中异动 早盘股价大跌5.24%报0.532美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516344637","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516344637?lang=zh_cn&edition=full","pubTime":"2025-03-03 23:05","pubTimestamp":1741014302,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日23时05分，Lineage Cell Therapeutics, Inc.股票出现异动，股价大幅下挫5.24%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.11%。其相关个股中，Bioxcel Therapeutics, Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028、Entero Therapeutics Inc.涨幅较大，Bioxcel Therapeutics, Inc.、Entero Therapeutics Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为1039.63%、125.32%、100.95%，振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Entero Therapeutics Inc.、Pliant Therapeutics, Inc.，振幅分别为163.15%、70.53%、48.34%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303230502a25d4a2b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303230502a25d4a2b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","LCTX","BK4139","BK4224","LINE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514833037","title":"Lineage Cell Therapeutics, Inc.盘中异动 股价大跌7.13%报0.582美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514833037","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514833037?lang=zh_cn&edition=full","pubTime":"2025-02-28 04:48","pubTimestamp":1740689324,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日04时48分，Lineage Cell Therapeutics, Inc.股票出现异动，股价快速跳水7.13%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.49%。其相关个股中，Pepgen Inc.、Ibio, Inc.、Cingulate Inc C/Wts 10/12/2026 涨幅较大，Quoin Pharmaceuticals Ltd、Aeon Biopharma, Inc.、Vincerx Pharma, Inc.较为活跃，换手率分别为1949.46%、414.29%、197.51%，振幅较大的相关个股有Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Pepgen Inc.、Pds Biotechnology Corporation，振幅分别为86.14%、67.32%、55.84%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228044844abdfc11f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228044844abdfc11f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LINE","LCTX","BK4139","LENZ","BK4224"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512651851","title":"Lineage Cell Therapeutics, Inc.盘中异动 早盘股价大涨5.04%报0.730美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512651851","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512651851?lang=zh_cn&edition=full","pubTime":"2025-02-18 22:41","pubTimestamp":1739889678,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日22时41分，Lineage Cell Therapeutics, Inc.股票出现波动，股价大幅拉升5.04%。截至发稿，该股报0.730美元/股，成交量20.4838万股，换手率0.09%，振幅3.25%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.49%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218224118abd3b177&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218224118abd3b177&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LCTX","BK4139","BK4224","LINE","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511522318","title":"Lineage Cell Therapeutics, Inc.盘中异动 股价大涨5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511522318","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2511522318?lang=zh_cn&edition=full","pubTime":"2025-02-13 23:51","pubTimestamp":1739461899,"startTime":"0","endTime":"0","summary":"北京时间2025年02月13日23时51分，Lineage Cell Therapeutics, Inc.股票出现异动，股价大幅上涨5.26%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.53%。其相关个股中，Edesa Biotech, Inc.、Pliant Therapeutics, Inc.、Dominari Holdings Inc.涨幅较大，Edesa Biotech, Inc.、Tc Biopharm  Plc、Genprex, Inc.较为活跃，换手率分别为2568.57%、1156.53%、159.27%，振幅较大的相关个股有Edesa Biotech, Inc.、Immatics N V C/Wts 01/07/2025 、Tc Biopharm  Plc C/Wts 10/02/2028 ，振幅分别为95.15%、92.30%、42.61%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021323514098843c1d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021323514098843c1d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LCTX","BK4224","LENZ","LINE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508463725","title":"Lineage Cell Therapeutics, Inc.盘中异动 早盘股价大跌5.08%报0.655美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2508463725","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2508463725?lang=zh_cn&edition=full","pubTime":"2025-02-04 23:30","pubTimestamp":1738683041,"startTime":"0","endTime":"0","summary":"北京时间2025年02月04日23时30分，Lineage Cell Therapeutics, Inc.股票出现波动，股价大幅下跌5.08%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.52%。其相关个股中，Azitra Inc、Evaxion Biotech As、Nutriband Inc C/Wts 涨幅较大，Azitra Inc、Evaxion Biotech As、Enveric Biosciences, Inc.较为活跃，换手率分别为1502.80%、880.18%、223.05%，振幅较大的相关个股有Azitra Inc、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Viracta Therapeutics, Inc.，振幅分别为64.17%、49.88%、44.22%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204233041a2393498&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204233041a2393498&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LINE","BK4224","LENZ","LCTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508448791","title":"Lineage Cell Therapeutics, Inc.盘中异动 早盘股价大涨6.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508448791","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2508448791?lang=zh_cn&edition=full","pubTime":"2025-02-03 22:58","pubTimestamp":1738594725,"startTime":"0","endTime":"0","summary":"北京时间2025年02月03日22时58分，Lineage Cell Therapeutics, Inc.股票出现异动，股价急速上涨6.14%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.53%。其相关个股中，Hcw Biologics Inc.、Gh Research Plc、Invivyd, Inc.涨幅较大，Hcw Biologics Inc.、Cyclerion Therapeutics, Inc.、Tonix Pharmaceuticals Holding Corp.较为活跃，换手率分别为472.52%、242.34%、80.29%，振幅较大的相关个股有Hcw Biologics Inc.、Invivyd, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为97.05%、64.33%、50.76%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020322584596170096&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020322584596170096&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","LINE","LCTX","BK4224","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2507961590","title":"Lineage Cell Therapeutics, Inc.盘中异动 快速拉升5.24%报0.659美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2507961590","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2507961590?lang=zh_cn&edition=full","pubTime":"2025-01-31 23:01","pubTimestamp":1738335673,"startTime":"0","endTime":"0","summary":"北京时间2025年01月31日23时01分，Lineage Cell Therapeutics, Inc.股票出现波动，股价大幅拉升5.24%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.39%。其相关个股中，Cyclerion Therapeutics, Inc.、Nls Pharmaceutics Ltd.、Nls Pharmaceutics Ltd C/Wts 02/02/2026涨幅较大，Nls Pharmaceutics Ltd.、Cyclerion Therapeutics, Inc.、Silexion Therapeutics Corp较为活跃，换手率分别为1716.96%、1249.13%、102.16%，振幅较大的相关个股有Nls Pharmaceutics Ltd C/Wts 02/02/2026、Cyclerion Therapeutics, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为63.20%、56.30%、46.27%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501312301139614eede&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501312301139614eede&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LINE","BK4224","BK4139","LENZ","LCTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2507670862","title":"Lineage Cell Therapeutics, Inc.盘中异动 下午盘股价大涨5.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2507670862","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2507670862?lang=zh_cn&edition=full","pubTime":"2025-01-31 04:11","pubTimestamp":1738267871,"startTime":"0","endTime":"0","summary":"北京时间2025年01月31日04时11分，Lineage Cell Therapeutics, Inc.股票出现波动，股价急速上涨5.36%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.47%。其相关个股中，Tectonic Therapeutic, Inc.、Alterity Therapeutics Limited、Dominari Holdings Inc.涨幅较大，Kazia Therapeutics Limited、Silexion Therapeutics Corp、Alterity Therapeutics Limited较为活跃，换手率分别为1812.37%、329.81%、254.04%，振幅较大的相关个股有Dominari Holdings Inc.、Cero Therapeutics Holdings, Inc.、Immatics N V C/Wts 01/07/2025 ，振幅分别为70.55%、65.98%、64.10%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250131041111961462d1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250131041111961462d1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","LINE","BK4224","BK4139","LCTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2507316076","title":"Lineage Cell Therapeutics, Inc.盘中异动 早盘急速上涨6.46%报0.671美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2507316076","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2507316076?lang=zh_cn&edition=full","pubTime":"2025-01-29 22:31","pubTimestamp":1738161081,"startTime":"0","endTime":"0","summary":"北京时间2025年01月29日22时31分，Lineage Cell Therapeutics, Inc.股票出现异动，股价急速拉升6.46%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.08%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250129223121a23366e7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250129223121a23366e7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","BK4224","LINE","LCTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2506581476","title":"Lineage Cell Therapeutics, Inc.盘中异动 下午盘大幅下跌5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2506581476","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2506581476?lang=zh_cn&edition=full","pubTime":"2025-01-28 04:02","pubTimestamp":1738008163,"startTime":"0","endTime":"0","summary":"北京时间2025年01月28日04时02分，Lineage Cell Therapeutics, Inc.股票出现异动，股价大幅下挫5.03%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.75%。其相关个股中，Akero Therapeutics, Inc.、Dogwood Therapeutics, Inc.、Tevogen Bio Holdings Inc.涨幅较大，Onconetix, Inc.、Dogwood Therapeutics, Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为2182.46%、1078.60%、269.13%，振幅较大的相关个股有Dogwood Therapeutics, Inc.、Onconetix, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028，振幅分别为108.60%、99.77%、65.16%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250128040243a231aad1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250128040243a231aad1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LCTX","BK4224","LENZ","LINE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2505201263","title":"Lineage Cell Therapeutics, Inc.盘中异动 快速跳水5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505201263","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2505201263?lang=zh_cn&edition=full","pubTime":"2025-01-23 23:00","pubTimestamp":1737644410,"startTime":"0","endTime":"0","summary":"北京时间2025年01月23日23时00分，Lineage Cell Therapeutics, Inc.股票出现异动，股价大幅下跌5.19%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.19%。其相关个股中，Hepion Pharmaceuticals, Inc.、Nutriband Inc C/Wts 、Revolution Medicines Inc C/Wts 17/12/2026 涨幅较大，Hepion Pharmaceuticals, Inc.、Quoin Pharmaceuticals Ltd、Vigil Neuroscience, Inc.较为活跃，换手率分别为2801.91%、567.32%、44.15%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Nutriband Inc C/Wts 、Dogwood Therapeutics, Inc.，振幅分别为54.22%、49.73%、36.43%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250123230010960e49df&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250123230010960e49df&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","LINE","BK4224","BK4139","LCTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2505721548","title":"Lineage Cell Therapeutics, Inc.盘中异动 股价大涨5.30%报0.620美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505721548","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2505721548?lang=zh_cn&edition=full","pubTime":"2025-01-22 22:53","pubTimestamp":1737557611,"startTime":"0","endTime":"0","summary":"北京时间2025年01月22日22时53分，Lineage Cell Therapeutics, Inc.股票出现异动，股价急速上涨5.30%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.22%。其相关个股中，Immunoprecise Antibodies Ltd.、Protagenic Therapeutics Inc C/Wts 29/04/2026 、Nutriband Inc.涨幅较大，Immunoprecise Antibodies Ltd.、Hepion Pharmaceuticals, Inc.、Cardio Diagnostics Holdings Inc.较为活跃，换手率分别为655.53%、130.34%、58.80%，振幅较大的相关个股有Immunoprecise Antibodies Ltd.、Immatics N V C/Wts 01/07/2025 、Cingulate Inc C/Wts 10/12/2026 ，振幅分别为47.48%、41.27%、28.15%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122225331a22bb6b0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122225331a22bb6b0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","LINE","LCTX","BK4224","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.lineagecell.com","stockEarnings":[{"period":"1week","weight":-0.027},{"period":"1month","weight":-0.0526},{"period":"3month","weight":-0.0924},{"period":"6month","weight":-0.4162},{"period":"1year","weight":-0.1},{"period":"ytd","weight":-0.3533}],"compareEarnings":[{"period":"1week","weight":0.0011},{"period":"1month","weight":0.0005},{"period":"3month","weight":0.0443},{"period":"6month","weight":0.1455},{"period":"1year","weight":0.1865},{"period":"ytd","weight":0.1294}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Lineage Cell Therapeutics, Inc.于1990年11月30日在加利福尼亚州注册成立。该公司是一家临床阶段的生物技术公司，专注于开发异体细胞替代疗法，以治疗因细胞丢失或功能障碍导致的严重疾病。其方法利用专有的制造平台，为多种适应症生产成熟的分化细胞。","yearOnYearQuotes":[{"month":1,"riseRate":0.555556,"avgChangeRate":0.066208},{"month":2,"riseRate":0.315789,"avgChangeRate":-0.02088},{"month":3,"riseRate":0.631579,"avgChangeRate":0.045349},{"month":4,"riseRate":0.315789,"avgChangeRate":-0.065235},{"month":5,"riseRate":0.421053,"avgChangeRate":-0.02946},{"month":6,"riseRate":0.421053,"avgChangeRate":0.027467},{"month":7,"riseRate":0.315789,"avgChangeRate":-0.031644},{"month":8,"riseRate":0.388889,"avgChangeRate":-0.0293},{"month":9,"riseRate":0.5,"avgChangeRate":0.022043},{"month":10,"riseRate":0.444444,"avgChangeRate":0.628473},{"month":11,"riseRate":0.388889,"avgChangeRate":-0.002727},{"month":12,"riseRate":0.555556,"avgChangeRate":0.016762}],"exchange":"AMEX","name":"Lineage Cell Therapeutics Inc","nameEN":"Lineage Cell Therapeutics Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Lineage Cell Therapeutics Inc(LCTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Lineage Cell Therapeutics Inc(LCTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Lineage Cell Therapeutics Inc,LCTX,Lineage Cell Therapeutics Inc股票,Lineage Cell Therapeutics Inc股票老虎,Lineage Cell Therapeutics Inc股票老虎国际,Lineage Cell Therapeutics Inc行情,Lineage Cell Therapeutics Inc股票行情,Lineage Cell Therapeutics Inc股价,Lineage Cell Therapeutics Inc股市,Lineage Cell Therapeutics Inc股票价格,Lineage Cell Therapeutics Inc股票交易,Lineage Cell Therapeutics Inc股票购买,Lineage Cell Therapeutics Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Lineage Cell Therapeutics Inc(LCTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Lineage Cell Therapeutics Inc(LCTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}